StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals PSUs — Total fair value of shares vested by Year

PSUs — Total fair value of shares vested ($M) ($M)

Vertex Pharmaceuticals PSUs — Total fair value of shares vested: $277M in FY2025, down 20.3% from a year earlier.

Latest, FY2025
277
Period ended Dec 31, 2025
Change on a year earlier
-20.3%
347 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-13) ↗

Reported in Form 10-K Note (Stock-based Compensation — PSU Rollforward).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPSUs — Total fair value of shares vested ($M) ($M)Year on yearSource
FY2025Dec 31, 2025277-20.3%Form 10-K (filed 2026-02-13) ↗
FY2024Dec 31, 2024347+116.4%Form 10-K (filed 2026-02-13) ↗
FY2023Dec 31, 2023160+62.5%Form 10-K (filed 2026-02-13) ↗
FY2022Dec 31, 202298.7+7.0%Form 10-K (filed 2025-02-13) ↗
FY2021Dec 31, 202192.2-33.4%Form 10-K (filed 2024-02-15) ↗
FY2020Dec 31, 2020139+88.9%Form 10-K (filed 2023-02-10) ↗
FY2019Dec 31, 201973.3+215.9%Form 10-K (filed 2022-02-09) ↗
FY2018Dec 31, 201823.2+1,684.6%Form 10-K (filed 2021-02-11) ↗
FY2017Dec 31, 20171.30–Form 10-K (filed 2020-02-13) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals PSUs — Total fair value of shares vested ($M), annual FY2017–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/psu-vested-tot-fv

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.